Today: 30 April 2026
Browse Category

NYSE:BSX 22 October 2025 - 15 January 2026

Boston Scientific’s $14.5B Penumbra buy: $374-a-share deal lifts PEN stock before the open

Boston Scientific’s $14.5B Penumbra buy: $374-a-share deal lifts PEN stock before the open

Boston Scientific will acquire Penumbra for about $14.5 billion, offering $374 per share in cash and stock. Penumbra shares rose more than 13% premarket, with the bid representing a 19.3% premium to the previous close. The deal expands Boston Scientific’s reach in catheter-based clot removal and neurovascular devices. Penumbra CEO Adam Elsesser will join Boston Scientific’s board.
15 January 2026
··
Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target as Valuation Debate Intensifies on Dec. 19, 2025

Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target as Valuation Debate Intensifies on Dec. 19, 2025

Boston Scientific shares traded at $95.76, down 0.36% as of 17:30 UTC Friday, after opening at $96.85 and moving between $95.64 and $97.24. The session coincided with December options expiration, with $7.1 trillion in contracts set to expire. UBS reiterated a Buy rating and $140 target, while Truist cut its target to $120. Trading volume Thursday reached 15.6 million shares, well above the 50-day average.
19 December 2025
·
Boston Scientific (BSX) Stock After Hours Dec. 18, 2025: Analyst Targets Shift, Options Point to Key Levels, and What to Watch Before Friday’s Open

Boston Scientific (BSX) Stock After Hours Dec. 18, 2025: Analyst Targets Shift, Options Point to Key Levels, and What to Watch Before Friday’s Open

Boston Scientific closed Thursday at $96.11, up 1.73%, with trading volume of 15.6 million shares, well above its 50-day average. After-hours trading was steady, with shares at $96.18 as of 6 p.m. ET. Truist Securities lowered its price target to $120 from $130 but kept a Buy rating. The stock remains 12.23% below its 52-week high of $109.50.
19 December 2025
·
Boston Scientific (BSX) Stock After Hours on Dec. 17, 2025: Analysts Stay Bullish as Shares Close Higher — What to Watch Before Thursday’s Open

Boston Scientific (BSX) Stock After Hours on Dec. 17, 2025: Analysts Stay Bullish as Shares Close Higher — What to Watch Before Thursday’s Open

Boston Scientific shares closed up 1.65% at $94.48 on Wednesday, outperforming the broader market as the S&P 500 fell 1.16%. The stock traded as high as $95.99 intraday and saw volume above its 50-day average. After-hours, BSX edged up to $94.70. The stock remains about 13.7% below its 52-week high set in September.
18 December 2025
·
Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target, RBC Raises to $130 as 2026 Catalysts Come Into Focus

Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target, RBC Raises to $130 as 2026 Catalysts Come Into Focus

UBS reiterated a Buy rating on Boston Scientific, keeping its $140 price target and citing upside potential into 2026. RBC raised its target to $130, while Canaccord Genuity adjusted to $131. BSX shares opened near $92.93, down about 10% in a month, with a market cap around $138 billion. Analysts point to growth in cardiac devices but warn on valuation and policy risks.
17 December 2025
·
Boston Scientific (BSX) Stock on December 10, 2025: Why Shares Are Sliding While the Growth Story Stays Intact

Boston Scientific (BSX) Stock on December 10, 2025: Why Shares Are Sliding While the Growth Story Stays Intact

Boston Scientific shares closed at $92.53 on December 9, down 1.4% and marking a seventh straight decline, with trading volume spiking to 12.7 million shares. The stock sits about 15% below its September high despite strong Q3 results, including 20% year-over-year sales growth and adjusted EPS of $0.75, beating forecasts. Over the past year, BSX remains slightly positive and is up about 170% over five years.
10 December 2025
··
Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets

Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets

Boston Scientific (BSX) closed at $98.57 on December 3, down slightly, with shares trading in a $97.60–$99.30 range. EVP Arthur Butcher sold 17,313 shares on December 1 for about $1.76 million under a pre-arranged plan. The stock is up roughly 8–9% over the past year but remains about 9.6% below its September high. The company also received new European device approvals this week.
4 December 2025
·
Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific (BSX) Stock Today: Price Slips as Neuromodulation Bull Case, Epic EHR Deal and Big Fund Moves Shape the Outlook – November 19, 2025

Boston Scientific shares fell 2.6% to $96.60 in late trading Wednesday, extending a three-day slide despite new research highlighting neuromodulation growth and recent acquisitions. The stock remains in the upper half of its 52-week range, with a market cap near $145–150 billion and trading at about 53 times trailing earnings.
19 November 2025
Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

U.S. stock indexes hover near record highs after the Dow gained 0.5% Tuesday, while the Nasdaq slipped 0.2% on tech earnings misses. About 85% of S&P 500 companies have beaten forecasts, the highest rate in four years. AMD surged to record highs on AI chip deals, while Eli Lilly hit $935 on obesity drug demand. Netflix fell 6–7% pre-market after an earnings miss; Texas Instruments dropped nearly 9% on weak guidance.
22 October 2025
···········
1 2

Stock Market Today

  • Stocks Mixed Ahead of Major Tech Earnings as Oil Prices Surge
    April 29, 2026, 6:34 PM EDT. U.S. stock indexes closed mixed Wednesday, with the Dow Jones hitting a 1.5-week low, dragged down by soaring crude oil prices that stoked inflation concerns. The S&P 500 slipped 0.04%, Dow fell 0.57%, while the tech-heavy Nasdaq 100 gained 0.58%, supported by strong AI demand and robust earnings from chipmakers NXP Semiconductors and Seagate Technology. The Federal Reserve held rates steady but three FOMC members dissented against easing, with Chair Powell signaling caution. Treasury yields climbed to a one-month high. Investors now eye earnings from tech giants Alphabet, Amazon, Microsoft, and Meta. Housing data showed mixed signals: March housing starts rose 10.8%, but building permits fell 10.8%. The U.S.-Iran naval blockade boosted oil prices over 6%, adding volatility to markets ahead.

Latest article

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Markel Stock Slides After $728 Million Investment Loss Masks Insurance Turnaround

Markel Stock Slides After $728 Million Investment Loss Masks Insurance Turnaround

30 April 2026
Markel Group posted a $212.3 million net loss for the first quarter, driven by a $728 million investment loss, sending shares down 7.9% to $1,759.21. Operating revenue held steady at $3.55 billion, while adjusted operating income rose 4% to $498 million. Markel Insurance’s adjusted operating income jumped 31% to $369 million. Gross premium volume in underwriting fell 21% after exiting Global Reinsurance.
QQQ Rises Today as Big Tech Earnings Put the Nasdaq 100 Rally on the Line

QQQ Rises Today as Big Tech Earnings Put the Nasdaq 100 Rally on the Line

30 April 2026
The Invesco QQQ Trust closed up $3.99 at $661.57 Wednesday as investors positioned ahead of earnings from Microsoft, Alphabet, Amazon, and Meta. Volume topped 30 million shares. Microsoft and Alphabet reported strong cloud and AI-driven revenue growth after the bell. The broader Nasdaq Composite edged up 0.04%, while the S&P 500 slipped 0.04%.
Go toTop